Here's Why Generic-Drug Manufacturers Were Down Monday
Forty-four states have brought a lawsuit against the industry.
Mylan
MYL
MYL
$19.64
-$0.57
-2.8%
BATS BZX Real Time Price as of May 17, 2019, 4:30 p.m.
View Interactive MYL Charts
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
News & Analysis: Mylan
The Fool has written over 200 articles on Mylan.
All
Market Moves
Podcasts
Earnings
Mylan N.V. (MYL) Q1 2019 Earnings Call Transcript
MYL earnings call for the period ending March 31, 2019.
Mylan's Struggles Continue in the First Quarter
The drugmaker's challenges in the U.S. generics market and problems at a manufacturing facility weighed on its first-quarter revenue and earnings.
Why Mylan Stock Is Sinking Today
The drugmaker's Q1 update is weighing on its share price.
Why Axon Enterprise, Mylan, and Weight Watchers International Slumped Today
A little-changed market still left these stocks lower.
Why Mylan Shares Are Sinking Today
The drugmaker's Q4 update had very few bright spots.
What's Behind Mylan's Disappointing Q4 Earnings?
The drugmaker's revenue and earnings fell because of continued weakness in the U.S. market.
Mylan (MYL) Q4 2018 Earnings Conference Call Transcript
MYL earnings call for the period ending December 31, 2018.
Why Mylan, Mosaic, and Martin Marietta Materials Jumped Today
Find out how these stocks fared on Election Day.
Why Mylan N.V. Stock Is Soaring Today
Better-than-expected Q3 earnings generated excitement for the drugmaker.
